About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 427640, 10 pages
http://dx.doi.org/10.1155/2013/427640
Research Article

Chronic Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity Decreases Hypertension, Insulin Resistance, and Hypertriglyceridemia in Metabolic Syndrome

Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, UW2521, P.O. Box 1539, 709 Swedeland Road, King of Prussia, PA 19406-0939, USA

Received 5 October 2012; Accepted 18 February 2013

Academic Editor: Joseph Fomusi Ndisang

Copyright © 2013 Christine G. Schnackenberg et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Christine G. Schnackenberg, Melissa H. Costell, Daniel J. Krosky, et al., “Chronic Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity Decreases Hypertension, Insulin Resistance, and Hypertriglyceridemia in Metabolic Syndrome,” BioMed Research International, vol. 2013, Article ID 427640, 10 pages, 2013. doi:10.1155/2013/427640